AnalystsInsight

H.C. Wainwright Analysts: Track Record and Price‑Target Accuracy

How accurate H.C. Wainwright’s equity analysts have been: their median price‑target hit rate, how their calls did a year later, how they compare by sector and who they are, from Exent’s 7‑year backtest.

Published Updated 3 min readHow we research

Key takeaways

  • 11 H.C. Wainwright analysts are in Exent’s ranking of the top 1,191.
  • Their median price‑target hit rate is 22.3% (all analysts: 53.0%).
  • A median 46.7% of their calls were up 12 months later.
  • Main sectors covered: Healthcare, Financials, Materials.
  • Most‑rated stocks: COIN, ALNY, INSM, BBIO.

Which stocks do Wall Street’s best‑ranked analysts agree on? See them in Exent Gems →

How accurate are H.C. Wainwright analysts?

Median across the firm’s analystsH.C. WainwrightAll analysts
Price‑target hit rate22.3%53.0%
Calls up after 12 months46.7%64.4%

H.C. Wainwright’s top‑ranked analysts

AnalystStarsHit rateCalls up after 12 months
???4.9★27.9%46.7%
???4.9★52.4%61.4%
???4.9★36.9%50.2%
???4.9★30.7%52.9%

Who H.C. Wainwright’s highest‑ranked analysts are, and what they are rating now, is in Exent Gems: the stocks where several top‑ranked analysts agree.

H.C. Wainwright analysts on Exent

AnalystSectorStarsPrice‑target hit rateCalls up after 12 months
Arthur He CFAHealthcare4.8★6.1%60.2%
Patrick TrucchioHealthcare4.8★7.6%44.3%
Andres Y. MaldonadoHealthcare4.8★22.3%55.4%
Swayampakula RamakanthHealthcare4.7★24.8%40.6%
Joseph PantginisHealthcare4.7★18.4%43.5%
Robert BurnsHealthcare4.5★21.6%35.7%
Ram SelvarajuHealthcare0.5★21.2%41.0%
  • Arthur He CFA
    Sector
    Healthcare
    Stars
    4.8★
    Price‑target hit rate
    6.1%
    Calls up after 12 months
    60.2%
  • Patrick Trucchio
    Sector
    Healthcare
    Stars
    4.8★
    Price‑target hit rate
    7.6%
    Calls up after 12 months
    44.3%
  • Andres Y. Maldonado
    Sector
    Healthcare
    Stars
    4.8★
    Price‑target hit rate
    22.3%
    Calls up after 12 months
    55.4%
  • Swayampakula Ramakanth
    Sector
    Healthcare
    Stars
    4.7★
    Price‑target hit rate
    24.8%
    Calls up after 12 months
    40.6%
  • Joseph Pantginis
    Sector
    Healthcare
    Stars
    4.7★
    Price‑target hit rate
    18.4%
    Calls up after 12 months
    43.5%
  • Robert Burns
    Sector
    Healthcare
    Stars
    4.5★
    Price‑target hit rate
    21.6%
    Calls up after 12 months
    35.7%
  • Ram Selvaraju
    Sector
    Healthcare
    Stars
    0.5★
    Price‑target hit rate
    21.2%
    Calls up after 12 months
    41.0%

The 7 H.C. Wainwright analysts with an open record and at least 20 price targets to measure, in Exent’s ranking order. Among them, Swayampakula Ramakanth has the highest price‑target hit rate (24.8% over 2,196 targets). The other 4 are among the top‑ranked analysts, whose names are for members. Stars combine hit rate, average return and the number of ratings, so a high star rating can come with a modest hit rate.

H.C. Wainwright analysts by sector

SectorH.C. Wainwright analysts (open record)H.C. Wainwright median hit rateAll ranked analysts in the sector
Healthcare721.2%42.9%

Median price‑target hit rate of the firm’s open‑record analysts in each sector where it has three or more, against the median of every ranked analyst in that sector. Small groups move a lot with one analyst, so read it as a lean, not a verdict.

Stocks H.C. Wainwright analysts rate most

StockRatings in the sample
COIN28
ALNY20
INSM19
BBIO13

Ratings counted over the 7‑year lookback, across all 11 ranked H.C. Wainwright analysts (each analyst’s most‑rated stocks), stocks with an Exent page only.

Exent’s top 50 analysts

Across 988,127 ratings, the average Wall Street analyst’s price target was reached 53.0% of the time: close to a coin flip. The spread between analysts is wide, and 14.4% of the 971 analysts with a measurable record reached 70% or more (Exent data, Nov 16, 2026).

Exent Gems is built on the top 50 of Exent’s ranking. Over the last two years, some of them reached 90% or more of their price targets. Who they are, which stocks they are calling now and how often they have been right is for members.

How this is measured

Firm figures are medians across the firm’s analysts in Exent’s ranking, so one star analyst does not carry the whole firm. Each analyst’s record is a 7‑year replay of their rated price targets. See the analyst rankings.

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Frequently asked questions

Across 11 H.C. Wainwright analysts in Exent’s ranking, the median price-target hit rate was 22.3% over a 7-year lookback, against 53.0% for all analysts.

Exent ranks 11 H.C. Wainwright analysts. Those with an open record include Arthur He CFA (healthcare), Patrick Trucchio (healthcare), Andres Y. Maldonado (healthcare), Swayampakula Ramakanth (healthcare), Joseph Pantginis (healthcare).

Exent ranks 11 H.C. Wainwright analysts by their 7-year record. The names and live calls of the top-ranked ones are members-only in Exent Gems (exent.ai/radar).

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.